We’re focused on developing and commercializing a range of first-in-class prescription and non-prescription gastrointestinal products for companion and production animals.
Jaguar is committed to identifying animal health market opportunities where we can develop species-specific products that leverage our broad intellectual property portfolio, deep pipeline and extensive botanical library.
Dec 4, 2014: Jaguar Animal Health Completes Equine Study for Safety & Palatability of Neonorm™ Foal Gastrointestinal Product READ MORE
Nov 21, 2014: Jaguar Animal Health Appoints Former Merial Executive to Head Regulatory Affairs READ MORE
Sep 29, 2014: Jaguar Animal Health, Inc. Launches First Product, Neonorm™ Calf, at World Dairy Expo READ MORE
Sep 17, 2014: Jaguar Animal Health, Inc. Files Eighth Investigational New Animal Drug Application READ MORE